This site is intended for healthcare professionals only
News
Share this article

Technology companies team up to support people with diabetes in cross-Europe bike tour

The third mHealth Grand Tour will take place between 3rd and 12th September and will cover 1500 km from Brussels to Geneva, via Paris.

The third mHealth Grand Tour will take place between 3rd and 12th September, covering 1500 km from Brussels to Geneva, via Paris. Open to cyclists with type 1 or type 2 diabetes, the tour aims to showcase what is possible for people with the condition and demonstrate how technology can address the challenge of managing it whilst still leading an active lifestyle.

Riders will be monitored remotely and will receive personalised coaching via their mobile devices to help them manage their condition throughout the tour. They will also be followed by a team of medical professionals who will provide expert advice based on real-time data gathered during the ride. Following the Tour, the riders’ data processed and analysed as part of an observational study on using information and communication technology conducted by Orange in association with the Société Francophone du Diabète.

Throughout the tour, riders will have access to technologies from the following sponsors:

  • Orange Healthcare will provide the secure collection, transmission and hosting of riders’ data to be shared securely with the medical team.
  • Samsung will provide mobile devices through which riders can access the medical coaching apps.
  • Intel will provide Basic Peak, which will enable the riders to monitor their physical condition and adjust their effort according to their fitness levels.
  • TAPcheck will supply riders with connected scales, blood pressure meters and glucose monitors.
  • Dexcom will provide continuous glucose monitors.
  • Continua’s interoperability Design Guidelines will enable the secure and seamless transmission of health data between wearable sensors, mobile devices and an electronic health record platform to capture rider data.

In addition, riders will also be provided with the latest innovations from two start-ups. Tellspec will enable the athletes to scan their food at a molecular level, so they can monitor the total intake of calories and carbohydrates per meal, per day and per week, and adjust the quantity of insulin required for each injection. MedWhat will provide smarter personalised diabetic medical advice through their cognitive and artificial intelligence technology.

The mHealth Grand Tour features professional and elite amateurs, club riders and novice riders, who can take part in a relay if preferred, all participating together. For more information, visit www.mhealthtour.com.

Related content
Prevention of diabetic maculopathy: Trial of oral medication begins
;
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.